(IVBT - INNOVATION1 BIOTECH INC)

company profile

Innovation1 Biotech Inc. focuses on researching, developing, producing, and selling pharmaceutical products. The company offers natural supplements for the treatment of symptoms associated with the flu and long covid under the NutraFlu and Nutravid19 brands; and other supplement and medical nutrition products. It also develops NLC001 that is in Phase II clinical trial for the treatment of long covid and other viral indications. The company is based in New York, New York.

Innovation1 Biotech (IVBT) is trading at 0.0002

Open Price
0.0002
Previous close
0.0002
Previous close
0.0002
P/E Ratio
0
Sector
Health Care
Shares outstanding
22470239
Primary exchange
OTC Markets
ISIN
US39809D2018